Charles E. Binkley, MD, Michael S. Politz, MA, and Brian P. Green, PhD
If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.
AMA J Ethics. 2021;23(9):E745-749. doi:
10.1001/amajethics.2021.745.
Climate change mitigation reforms of government policy, medical curricula, and health professions organizations should be the focus of physician advocacy.
AMA J Ethics. 2017;19(12):1222-1237. doi:
10.1001/journalofethics.2017.19.12.sect1-1712.